RS Crum Inc’s iShares Biotechnology ETF IBB Stock Holding History

RS Crum Inc’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.73M	Sell	9,111 -340	-4%	-$58.4K	0.32%	30
2026 Q1	$1.6M	Hold	9,451	–	–	0.31%	33
2025 Q4	$1.6M	Hold	9,451	–	–	0.32%	30
2025 Q3	$1.36M	Hold	9,451	–	–	0.3%	32
2025 Q2	$1.2M	Hold	9,451	–	–	0.29%	32
2025 Q1	$1.21M	Sell	9,451 -205	-2%	-$27.8K	0.33%	31
2024 Q4	$1.28M	Hold	9,656	–	–	0.32%	32
2024 Q3	$1.41M	Sell	9,656 -127	-1%	-$18.4K	0.33%	31
2024 Q2	$1.34M	Hold	9,783	–	–	0.35%	31
2024 Q1	$1.34M	Sell	9,783 -145	-1%	-$19.8K	0.37%	30
2023 Q4	$1.35M	Sell	9,928 -160	-2%	-$19.5K	0.42%	30
2023 Q3	$1.23M	Hold	10,088	–	–	0.44%	32
2023 Q2	$1.28M	Sell	10,088 -21	-0.2%	-$2.73K	0.46%	33
2023 Q1	$1.31M	Hold	10,109	–	–	0.5%	31
2022 Q4	$1.33M	Sell	10,109 -2,965	-23%	-$383K	0.62%	30
2022 Q3	$1.53M	Hold	13,074	–	–	0.8%	21
2022 Q2	$1.54M	Hold	13,074	–	–	0.79%	22
2022 Q1	$1.7M	Sell	13,074 -288	-2%	-$37.5K	0.96%	20
2021 Q4	$2.04M	Buy	+13,362	New	+$2.07M	1.13%	18

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

RS Crum Inc's IBB Position: Q2 2026 in Review

RS Crum Inc reduced its iShares Biotechnology ETF (IBB) stake by 3.6% in Q2 2026, selling an estimated $58.4K and leaving 9,111 shares worth $1.73M. The position accounts for 0.32% of the portfolio, ranked #30.

RS Crum Inc first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.04M in Q4 2021. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

RS Crum Inc held 9,111 shares of iShares Biotechnology ETF worth $1.73M as of Q2 2026.
RS Crum Inc sold 340 iShares Biotechnology ETF shares in Q2 2026, an estimated $58.4K.
iShares Biotechnology ETF made up 0.32% of RS Crum Inc's portfolio in Q2 2026, its #30 holding.
RS Crum Inc first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
RS Crum Inc's iShares Biotechnology ETF position peaked at $2.04M in Q4 2021.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on RS Crum Inc's 13F filing for Q2 2026, filed 10 Aug 2026.